BioXcel Therapeutics Agrees To Teva Asset Sale
(RTTNews) - BioXcel Therapeutics Inc. (BTAI) on Friday entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH (TEVA.TA) and filed for voluntary Chapter 11 bankruptcy.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.